AstraZeneca Aktie
177,50
EUR
+4,45
EUR
+2,57
%
154,86
GBP
+3,26
GBP
+2,15
%
AstraZeneca jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Diese Analysten bewerten die AstraZeneca-Aktie
| Analyst | Kursziel | Abstand Kursziel | Datum | |
|---|---|---|---|---|
| Deutsche Bank AG | 115,00 GBP | - | 16.02.2026 | |
| Bernstein Research | 205,00 GBP | - | 13.02.2026 | |
| DZ BANK | - | - | 12.02.2026 | |
| Barclays Capital | 165,00 GBP | - | 11.02.2026 | |
| UBS AG | 163,00 GBP | - | 10.02.2026 | |
| Jefferies & Company Inc. | 150,00 GBP | - | 10.02.2026 | |
| JP Morgan Chase & Co. | 160,00 GBP | - | 10.02.2026 | |
| Goldman Sachs Group Inc. | 163,89 GBP | - | 28.01.2026 | |
| Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | 1,60 GBP | - | 28.01.2026 |
Werbung
Kursziele im Branchenvergleich
| Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
|---|---|---|---|---|---|
| Abbott Laboratories | 0 | 0 | 0 | - | - |
| Alexion Pharmaceuticals Inc. | 0 | 0 | 0 | - | - |
| APONTIS PHARMA | 0 | 0 | 0 | - | - |
| AstraZeneca PLC | 7 | 1 | 1 | 140,44 GBP | - |
| Bayer | 5 | 5 | 0 | 37,83 EUR | -21,30% |
| BioNTech (ADRs) | 4 | 2 | 0 | 136,50 USD | +28,96% |
| CanSino Biologics Inc. Registered Shs -A- | 0 | 0 | 0 | - | - |
| Celgene Corp. | 0 | 0 | 0 | - | - |
| CureVac | 0 | 1 | 0 | - | - |
| EVOTEC SE | 2 | 1 | 0 | 8,67 EUR | +43,54% |
| Gilead Sciences Inc. | 0 | 0 | 0 | - | - |
| Johnson & Johnson | 0 | 0 | 0 | - | - |
| Merck Co. | 0 | 0 | 0 | - | - |
| Merck KGaA | 4 | 3 | 0 | 141,17 EUR | +13,80% |
| Moderna Inc | 0 | 0 | 0 | - | - |
| Novartis AG | 3 | 5 | 1 | 115,00 CHF | -10,48% |
| Novavax Inc. | 0 | 0 | 0 | - | - |
| Pfizer Inc. | 1 | 5 | 0 | 28,33 USD | +3,49% |
| Roche AG (Genussschein) | 4 | 4 | 1 | 347,88 CHF | -5,60% |
| Roche Holding AG (Inhaberaktie) | 0 | 0 | 0 | - | - |
| Sanofi S.A. | 5 | 4 | 0 | 97,62 EUR | +24,66% |
| Shanghai Fosun Pharmaceutical (Group) Co Ltd (A) | 0 | 0 | 0 | - | - |
| Sinovac Biotech LtdShs | 0 | 0 | 0 | - | - |
| STADA | 0 | 0 | 0 | - | - |
| Teva Pharmaceutical Industries Ltd. (spons. ADRs) | 0 | 0 | 0 | - | - |
| Valneva | 0 | 0 | 0 | - | - |
| Vertex Pharmaceuticals Inc. | 0 | 0 | 0 | - | - |
| Warner Chilcott plc | 0 | 0 | 0 | - | - |